Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer
{{output}}
The prognosis of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) remains poor, with most patients presenting with primary or acquired resistance to immune checkpoint inhibitors (ICIs). Upon progression on ICIs, the only standard of care trea... ...
